Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9394 |
High Similarity |
NPD3818 |
Discontinued |
0.9281 |
High Similarity |
NPD7472 |
Approved |
0.9222 |
High Similarity |
NPD7054 |
Approved |
0.9167 |
High Similarity |
NPD7074 |
Phase 3 |
0.9118 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.9059 |
High Similarity |
NPD7251 |
Discontinued |
0.9006 |
High Similarity |
NPD7808 |
Phase 3 |
0.9 |
High Similarity |
NPD6797 |
Phase 2 |
0.8909 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8727 |
High Similarity |
NPD2801 |
Approved |
0.8667 |
High Similarity |
NPD1934 |
Approved |
0.8596 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8596 |
High Similarity |
NPD6166 |
Phase 2 |
0.8596 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8555 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8512 |
High Similarity |
NPD3882 |
Suspended |
0.8512 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8503 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8471 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8409 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8323 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8249 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8235 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8182 |
Intermediate Similarity |
NPD1511 |
Approved |
0.814 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8129 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8101 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.8098 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8095 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8084 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8079 |
Intermediate Similarity |
NPD7228 |
Approved |
0.807 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8034 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8022 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7965 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7929 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7892 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7886 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7879 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7861 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7821 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7818 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7818 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7816 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7814 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7814 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7811 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7811 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7803 |
Intermediate Similarity |
NPD37 |
Approved |
0.7797 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7797 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7797 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7771 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7771 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7771 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7758 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7753 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7746 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7719 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7708 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7708 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7708 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7708 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7708 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7708 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7708 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7705 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7697 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.768 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7665 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7654 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7653 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7647 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7627 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7611 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7611 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7602 |
Intermediate Similarity |
NPD5401 |
Approved |
0.759 |
Intermediate Similarity |
NPD7697 |
Approved |
0.759 |
Intermediate Similarity |
NPD7698 |
Approved |
0.759 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7584 |
Intermediate Similarity |
NPD919 |
Approved |
0.7551 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7551 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7544 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7538 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7525 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7486 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7473 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7471 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7455 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7455 |
Intermediate Similarity |
NPD943 |
Approved |
0.7455 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7455 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.745 |
Intermediate Similarity |
NPD7874 |
Approved |
0.745 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7448 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7448 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7427 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7423 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7423 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7414 |
Intermediate Similarity |
NPD920 |
Approved |
0.7413 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7412 |
Intermediate Similarity |
NPD2800 |
Approved |
0.741 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7399 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7399 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7399 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7374 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7365 |
Intermediate Similarity |
NPD1607 |
Approved |
0.736 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7353 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7337 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7305 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7296 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7267 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7264 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7259 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7225 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7214 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7212 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7209 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7207 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7202 |
Intermediate Similarity |
NPD447 |
Suspended |
0.72 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7194 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7166 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.715 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7135 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7135 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7135 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7128 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7128 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7128 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7114 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7114 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.711 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.711 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7105 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7095 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7093 |
Intermediate Similarity |
NPD2344 |
Approved |
0.709 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7086 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7076 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7076 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7069 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7039 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7039 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7033 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7031 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7009 |
Intermediate Similarity |
NPD8058 |
Clinical (unspecified phase) |
0.7009 |
Intermediate Similarity |
NPD8059 |
Phase 3 |
0.7006 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6989 |
Remote Similarity |
NPD5711 |
Approved |
0.6989 |
Remote Similarity |
NPD5710 |
Approved |
0.6977 |
Remote Similarity |
NPD651 |
Clinical (unspecified phase) |
0.6971 |
Remote Similarity |
NPD7930 |
Approved |
0.6948 |
Remote Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.6946 |
Remote Similarity |
NPD9494 |
Approved |
0.6935 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6934 |
Remote Similarity |
NPD7907 |
Approved |
0.6932 |
Remote Similarity |
NPD2309 |
Approved |
0.6931 |
Remote Similarity |
NPD5005 |
Approved |
0.6931 |
Remote Similarity |
NPD5006 |
Approved |
0.6927 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6923 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6923 |
Remote Similarity |
NPD6841 |
Approved |
0.6923 |
Remote Similarity |
NPD6843 |
Phase 3 |
0.6923 |
Remote Similarity |
NPD6842 |
Approved |
0.6919 |
Remote Similarity |
NPD4360 |
Phase 2 |
0.6919 |
Remote Similarity |
NPD4363 |
Phase 3 |
0.6915 |
Remote Similarity |
NPD2403 |
Approved |
0.6912 |
Remote Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.6905 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6897 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6886 |
Remote Similarity |
NPD2798 |
Approved |
0.6879 |
Remote Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.6879 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6862 |
Remote Similarity |
NPD5242 |
Approved |
0.6854 |
Remote Similarity |
NPD7390 |
Discontinued |
0.684 |
Remote Similarity |
NPD4111 |
Phase 1 |
0.684 |
Remote Similarity |
NPD4665 |
Approved |
0.6825 |
Remote Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.6816 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6816 |
Remote Similarity |
NPD4420 |
Approved |
0.6809 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6807 |
Remote Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.6805 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6802 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6802
|
Remote Similarity |
NPD4287 |
Approved |